The role of uric acid in protection against peroxynitrite-mediated pathology

Medical Hypotheses

Volumn 56, Issue 1, 2001, Pages 95-100

  Scott, G S ^a   Hooper, D C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE; URIC ACID;

ALLERGIC ENCEPHALOMYELITIS; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CELL PROTECTION; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0035165647     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1118     Document Type: Article

References (66)

1. The biological significance of uric acid and guanine excretion
2. Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes
3. Uricase protein sequences: Conserved during hominid evolution but absent in humans
4. Biochemistry of uric acid and its relation to gout
5. Two independent mutational events in the loss of urate oxidase during hominid evolution
6. Molecular evolution of the urate oxidase-encoding gene in hominid primates: Nonsense mutations
7. 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants
8. Uric acid provides an antioxidant- and radical-caused aging and cancer: A hypothesis
9. Inactivation of alpha-1-antiproteinase by hydroxyl radicals. The effect of uric acid
10. Nitric oxide-mediated neuronal injury in multiple sclerosis
11. The role of reactive oxygen species in the pathogenesis of multiple sclerosis
12. Demyelination: The role of reactive oxygen and nitrogen species
13. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
14. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
15. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases
16. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis
17. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: An electron paramagnetic resonance study
18. Local nitric oxide production in viral and autoimmune diseases of the central nervous system
19. -: Implications for the treatment of multiple sclerosis
20. Oral administration of the oxidant scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis
21. Suppression of hyperacute and passively transferred experimental autoimmune encephalomyelitis by the anti-oxidant, butylated hydroxyanisole
22. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites
23. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice
24. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells
25. --induced lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
26. Endogenous peroxynitrite is involved in the inhibition of cellular respiration in immuno-stimulated J774.2 macrophages
27. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
28. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon γ
29. Assembly and regulation of NADPH oxidase and nitric oxide synthase
30. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis
31. Protein kinase C and tyrosine kinase pathways regulate lipopolysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages
32. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. A kinetic analysis
33. Agonist-induced peroxynitrite production from endothelial cells
34. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage
35. --mediated tyrosine nitration catalyzed by superoxide dismutase
36. - oxidations by carbon dioxide
37. --mediated oxidations
38. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination
39. DNA damage induced by peroxynitrite: Subsequent biological effects
40. Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly (ADP-ribose) synthetase (PARS) activation
41. Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity
42. --mediated DNA strand breakage activates polyadenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide
43. - activity during progressive stages of central nervous system inflammation
44. - in inflammatory CNS demyelination
45. Uric acid, a peroxynitrite-scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis
46. Peroxynitrite formation within the central nervous system in active multiple sclerosis
47. Fas and fas ligand enhance the pathogenesis of experimental autoimmune encephalomyelitis, but are not essential for immune privilege in the central nervous system
48. Fas- and fasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
49. -, in experimental allergic encephalomyelitis and multiple sclerosis
50. Protection from free-radical mediated pathology by the natural peroxynitrite scavenger uric acid
51. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis
52. Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis
53. Increased concentrations of uric acid in the spinal cord of rats with chronic relapsing experimental allergic encephalomyelitis
54. A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis
55. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis
56. Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis
57. Transendothelial permeability changes induced by free radicals in an in vitro blood-brain barrier
58. Inflammatory events at the blood-brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species
59. Similar functions of uric acid and ascorbate in man?
60. Origin of Man
61. Uric acid and achievement
62. Assay of antioxidant capacity of human plasma and CSF in aging and disease
63. Antioxidant protection against hypochlorous acid in human plasma
64. Neurodegenerative disorders: The role of peroxynitrite
65. Oxidative stress in brain ischemia
66. Uric acid is reduced in the substantia nigra in Parkinson's disease: Effect on dopamine oxidation